Iman Nasr

667 total citations
19 papers, 94 citations indexed

About

Iman Nasr is a scholar working on Genetics, Pathology and Forensic Medicine and Rheumatology. According to data from OpenAlex, Iman Nasr has authored 19 papers receiving a total of 94 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Genetics, 5 papers in Pathology and Forensic Medicine and 4 papers in Rheumatology. Recurrent topics in Iman Nasr's work include Urticaria and Related Conditions (4 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (4 papers) and Drug-Induced Adverse Reactions (3 papers). Iman Nasr is often cited by papers focused on Urticaria and Related Conditions (4 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (4 papers) and Drug-Induced Adverse Reactions (3 papers). Iman Nasr collaborates with scholars based in Oman, United Kingdom and Kuwait. Iman Nasr's co-authors include Chad Cannon, Paul J. Ciclitira, Ania Manson, Hilary Longhurst, Mohamed Abuzakouk, Fuju Chang, Suzanne Donnelly, Mona Al‐Ahmad, Zainab Ansari and Fang Lei and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Allergy and Clinical Immunology and Frontiers in Immunology.

In The Last Decade

Iman Nasr

17 papers receiving 93 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Iman Nasr Oman 5 24 18 17 17 16 19 94
Shyam Joshi United States 8 11 0.5× 28 1.6× 9 0.5× 43 2.5× 12 0.8× 25 178
Sepideh Darougar Iran 6 3 0.1× 21 1.2× 15 0.9× 15 0.9× 5 0.3× 31 121
Rasol Molatefi Iran 8 4 0.2× 21 1.2× 13 0.8× 8 0.5× 51 3.2× 15 166
Toyota Ishii Japan 7 4 0.2× 31 1.7× 11 0.6× 30 1.8× 5 0.3× 24 231
Paolo Sena Italy 6 15 0.6× 18 1.0× 16 0.9× 25 1.5× 34 2.1× 19 120
Hanna Szymanik-Grzelak Poland 6 4 0.2× 12 0.7× 33 1.9× 30 1.8× 6 0.4× 20 108
E. Kondratyeva Russia 10 20 0.8× 17 0.9× 14 0.8× 24 1.5× 107 308
Narges Eslami Iran 9 11 0.5× 12 0.7× 18 1.1× 6 0.4× 1 0.1× 21 139
G. B. Pajno Italy 8 32 1.3× 16 0.9× 15 0.9× 60 3.5× 44 2.8× 16 251
Eoin R. Storan Ireland 6 3 0.1× 7 0.4× 33 1.9× 24 1.4× 23 1.4× 14 159

Countries citing papers authored by Iman Nasr

Since Specialization
Citations

This map shows the geographic impact of Iman Nasr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iman Nasr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iman Nasr more than expected).

Fields of papers citing papers by Iman Nasr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iman Nasr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iman Nasr. The network helps show where Iman Nasr may publish in the future.

Co-authorship network of co-authors of Iman Nasr

This figure shows the co-authorship network connecting the top 25 collaborators of Iman Nasr. A scholar is included among the top collaborators of Iman Nasr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iman Nasr. Iman Nasr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Dimou, Maria, Mohamed Abuzakouk, Mona Al‐Ahmad, et al.. (2024). Management of secondary immunodeficiency in hematological malignancies: a Delphi consensus from the Middle East. SHILAP Revista de lepidopterología. 3. 1 indexed citations
2.
Alshekaili, Jalila, et al.. (2023). A homozygous loss-of-function C1S mutation is associated with Kikuchi-Fujimoto disease. Clinical Immunology. 252. 109646–109646.
3.
Al‐Ahmad, Mona, Saad Alsaleh, Iman Nasr, et al.. (2022). Expert Opinion on Biological Treatment of Chronic Rhinosinusitis with Nasal Polyps in the Gulf Region. SHILAP Revista de lepidopterología. 14 indexed citations
4.
Maurer, Marcus, Mohamed Abuzakouk, Mona Al‐Ahmad, et al.. (2022). Consensus on diagnosis and management of Hereditary Angioedema in the Middle East: A Delphi initiative. World Allergy Organization Journal. 16(1). 100729–100729. 4 indexed citations
5.
Nasr, Iman, et al.. (2022). Successful Desensitization to the Radiocontrast Material Iohexol (Omnipaque™). Cureus. 14(12). e32356–e32356. 1 indexed citations
6.
Nasr, Iman, et al.. (2022). Real World Management of Anaphylaxis Versus the National Institute for Health and Clinical Excellence (NICE) Guidelines. Cureus. 14(9). e29336–e29336. 2 indexed citations
7.
Alshekaili, Jalila, et al.. (2022). Immune Dysregulation in Monogenic Inborn Errors of Immunity in Oman: Over A Decade of Experience From a Single Tertiary Center. Frontiers in Immunology. 13. 849694–849694. 1 indexed citations
8.
Balushi, Asma Al, Jalila Alshekaili, Zainab Ansari, et al.. (2021). Immunological predictors of disease severity in patients with COVID-19. International Journal of Infectious Diseases. 110. 83–92. 15 indexed citations
9.
Mestiri, Souhir, et al.. (2020). Implication of VDR rs7975232 and FCGR2A rs1801274 gene polymorphisms in the risk and the prognosis of autoimmune thyroid diseases in the Tunisian population. SHILAP Revista de lepidopterología. 23(1). 69–76. 4 indexed citations
10.
Nasr, Iman, et al.. (2018). Food-Dependent Exercise-Induced Anaphylaxis: An Overview. 6(2). 1–3. 1 indexed citations
11.
Nasr, Iman, et al.. (2016). Celiac disease, wheat allergy and non celiac gluten sensitivity. 3(4). 4 indexed citations
12.
Nasr, Iman, et al.. (2016). Antibiotic Allergy, When to Test, Challenge or Desensitise. Journal of Medical Microbiology & Diagnosis. 5(3).
13.
Nasr, Iman, et al.. (2015). Optimizing hereditary angioedema management through tailored treatment approaches. Expert Review of Clinical Immunology. 12(1). 19–31. 11 indexed citations
14.
Aygören‐Pürsün, Emel, Markus Magerl, Jochen Graff, et al.. (2015). Efficacy Correlates with Plasma Levels in Opus-1, a Proof-of-Concept Study of Oral Kallikrein Inhibitor BCX4161 As a Prophylaxis Against Attacks of Hereditary Angioedema (HAE). Journal of Allergy and Clinical Immunology. 135(2). AB192–AB192. 4 indexed citations
15.
Nasr, Iman, et al.. (2015). Recognising and Managing Refractory Coeliac Disease: A Tertiary Centre Experience. Nutrients. 7(12). 9896–9907. 12 indexed citations
16.
Magerl, Markus, Emel Aygören‐Pürsün, Jochen Graff, et al.. (2015). BCX4161, an Oral Kallikrein Inhibitor, Showed Significant Benefits on Reducing Disease Burden and Improving Quality of Life in Subjects with Hereditary Angioedema in the Opus-1 Study. Journal of Allergy and Clinical Immunology. 135(2). AB278–AB278. 4 indexed citations
17.
Nasr, Iman, et al.. (2014). Penicillin allergy diagnosis and desensitization. British Journal of Hospital Medicine. 75(Sup7). C98–C102. 1 indexed citations
18.
Cannon, Chad, et al.. (2004). The correlation of carboxyhemoglobin levels between venous and arterial blood gas samples. Annals of Emergency Medicine. 44(4). S55–S55. 3 indexed citations
19.
Cannon, Chad, et al.. (2004). Arterial and venous ionized calcium measurements: Is there a difference?. Annals of Emergency Medicine. 44(4). S56–S56. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026